Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 312Carcinoma, Non-Small-Cell Lung 282Prostatic Neoplasms 161Colorectal Neoplasms 155Carcinoma, Hepatocellular 145Neoplasms 135Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 107Triple Negative Breast Neoplasms 103Multiple Myeloma 101Recurrence 99Pancreatic Neoplasms 94Stomach Neoplasms 93Neoplasm Metastasis 87Ovarian Neoplasms 86Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Head and Neck Neoplasms 63Rectal Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 58Lymphoma 55Myelodysplastic Syndromes 54Esophageal Squamous Cell Carcinoma 54

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Amyotrophic Lateral Sclerosis × Clear all
NCT07002034 2026-06-03

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡